Decytabine enhances cytotoxicity induced by oxaliplatin and 5-fluorouracil in the colorectal cancer cell line Colo-205

Cancer Cell International

Volumn 9, Issue , 2009, Pages

  Flis, Sylwia ^a   Gnyszka, Agnieszka ^a   Misiewicz Krzemińska, Irena ^a   Spławiński, Jacek ^a  

^a NATIONAL MEDICINES INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DECYTABINE; DNA METHYLTRANSFERASE INHIBITOR; FLUOROURACIL; MESSENGER RNA; OXALIPLATIN; UNCLASSIFIED DRUG; ZEBULARINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL SURVIVAL; COLORECTAL CANCER; COMBINATION CHEMOTHERAPY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOTHERAPY;

EID: 66049110526     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-9-10     Document Type: Article

References (19)

1. Ohtani-Fujita N Fujita T Aoike A Osifchin NE Robbins PD Sakai T CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene Oncogene 1993, 8:1063-1067. 8455933
2. Herman JG Latif F Weng Y Lerman MI Zbar B Liu S Samid D Duan DS Gnarra JR Linehan WM Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma Proc Natl Acad Sci USA 1994, 91:9700-9704. 44884 7937876 10.1073/pnas.91.21.9700
3. Herman JG Jen J Merlo A Baylin SB Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4b Cancer Res 1996, 56:722-727. 8631003
4. Mancini DN Rodenhiser DI Ainsworth PJ O'Malley FP Singh SM Xing W Archer TK CpG methylation within the 59 regulatory regions of the BRCA1 gene is tumor specific and includes a putative CREB binding site Oncogene 1998, 16:1161-1169. 10.1038/sj.onc.1201630 9528858
5. Kanai Y Ushijima S Hui AM Ochiai A Tsuda H Sakamoto M Hirohashi S The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas Int J Cancr 1997, 71:355-359. 10.1002/ (SICI)1097-0215(19970502)71:3<355::AID-IJC8>3.0.CO;2-X 9139867
6. Esteller M Corn PG Urena JM Gabrielson E Baylin SB Herman JG Inactivation of glutathione S-transferase P1 gene by promoter hypermethylation in human neoplasia Cancer Res 1998, 58:4515-4518. 9788592
7. Myohanen SK Baylin SB Herman JG Hypermethylation can selectively silence individual p16INK4a alleles in neoplasia Cancer Res 1998, 58:591-593. 9485004
8. Grady WM Epigenetic events in the colorectum and in colon cancer Biochem Soc Tran 2005, 33:684-688. 10.1042/BST0330684
9. Cormier RT Dove WF Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele Cancer Res 2000, 60:3965-3970. 10919675
10. Gessner PK Isobolographic analysis of interactions: An update on applications and utility Toxicology 1995, 105:161-179. 10.1016/ 0300-483X(95)03210-7 8571354
11. Chou TC Talalay P Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 1984, 22:27-55. 10.1016/0065-2571(84)90007-4 6382953
12. Chou TC Talalay P Analysis of combined drug effects: A new look at a very old problem Trends Pharmacol Sci 1983, 4:450-454. 10.1016/ 0165-6147(83)90490-X
13. Smiley ST Reers M Mottola-Hartshorn C Lin M Chen A Smith TW Steele GD Jr Chen LB Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1 Proc Natl Acad Sci 1991, 88:3671-3675. 51514 2023917 10.1073/pnas.88.9.3671
14. Hellebrekers DM Griffioen AW van Engeland M Dual targeting of epigenetic therapy in cancer BBA 2007, 1775:76-91. 16930846
15. Chau I Cunningham D Adjuvant therapy in colon cancer-what, when and how? Ann Oncol 2006, 17:1347-59. 10.1093/annonc/mdl029 16524974
16. Peters GJ Wilt Van Der CL Van Moorsel CJA Kroep JR Bergman AM Ackland SP Basis for effective combination cancer chemotherapy with antimetabolites Pharmacol Therapeut 2000, 87:227-253. 10.1016/S0163-7258(00)00086-3
17. Goffin J Eisenhauer E DNA methyltransferase inhibitors-state of the art Ann Oncol 2002, 13:1699-1716. 10.1093/annonc/mdf314 12419742
18. Palii S Van Emburgh B Sankpal U Brown K Robertson K Methylation Inhibitor 5-Aza-2′-Deoxycytidine Induces Reversible Genome-Wide DNA Damage That Is Distinctly Influenced by DNA Methyltransferases 1 and 3B Mol Cell Biol 2008, 28:752-771. 2223421 17991895 10.1128/MCB.01799-07
19. Kurz EU Lees-Miller SP DNA damage-indiuced activation of ATM and ATM-dependent signaling pathways DNA Repair 2004, 3:889-900. 10.1016/ j.dnarep.2004.03.029 15279774